ClearBridge Investments
WST icon

ClearBridge Investments’s West Pharmaceutical WST Stock Holding History

ClearBridge Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,521
Closed -$1.49M – 753
2024
Q2 		$1.49M Buy
4,521
+26
+0.6% +$9.19K ﹤0.01% 645
2024
Q1 		$1.78M Buy
4,495
+31
+0.7% +$11.5K ﹤0.01% 633
2023
Q4 		$1.57M Buy
+4,464
New +$1.58M ﹤0.01% 638

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments's WST Position: Q3 2024 in Review

ClearBridge Investments sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 4,521 shares — an estimated $1.49M sold.

ClearBridge Investments first reported a position in WST in Q4 2023 and held it in 3 quarters. The position peaked at $1.78M in Q1 2024. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • ClearBridge Investments reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • ClearBridge Investments sold 4,521 West Pharmaceutical shares in Q3 2024, an estimated $1.49M.
  • ClearBridge Investments first reported a position in West Pharmaceutical in Q4 2023 and held it in 3 quarters.
  • ClearBridge Investments's West Pharmaceutical position peaked at $1.78M in Q1 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on ClearBridge Investments's 13F filing for Q3 2024, filed 12 Nov 2024.